HKG:0874 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 22.47B CNY in the quarter ending March 31, 2025, a decrease of -2.06%. This brings the company's revenue in the last twelve months to 74.52B, down -3.01% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.

Revenue (ttm)

74.52B CNY

Revenue Growth

-3.01%

P/S Ratio

0.54

Revenue / Employee

2.66M CNY

Employees

28,048

Market Cap

43.36B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%
Dec 31, 2020	61.67B	-3.28B	-5.05%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Jan 1, 2018	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeiGene	29.60B
Hansoh Pharmaceutical Group Company	13.05B
JD Health International	61.89B
WuXi Biologics	19.87B
Innovent Biologics	10.03B
Akeso	2.26B
Alibaba Health Information Technology	31.39B
CSPC Pharmaceutical Group	30.87B

Revenue Rankings